Miao Y. Chen

Beijing, 100730, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 139 publications

Splenic Angiosarcoma Misdiagnosed as PrimaryMyelofibrosis: Report of Two Cases and a Literature Review.

Splenic Angiosarcoma Misdiagnosed as PrimaryMyelofibrosis: Report of Two Cases and a Literature Review.

Journal: Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae

Published: June 25, 2026

River Diversity Outcomes at Different Trophic Levels Can Be Greater Than Expected When Land Use and Physical and Toxic Stressors Combine.

River Diversity Outcomes at Different Trophic Levels Can Be Greater Than Expected When Land Use and Physical and Toxic Stressors Combine.

Journal: Environmental science & technology

Published: May 26, 2026

A prospective, phase IV study of ixazomib, pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma.

A prospective, phase IV study of ixazomib, pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma.

Journal: British journal of haematology

Published: March 27, 2026

Case Report: HCV-triggered porphyria cutanea tarda in a patient with SEC23B-mutated congenital dyserythropoietic anemia type II.

Case Report: HCV-triggered porphyria cutanea tarda in a patient with SEC23B-mutated congenital dyserythropoietic anemia type II.

Journal: Frontiers in medicine

Published: February 25, 2026

Sirolimus for Refractory/relapsed Warm Autoimmune Hemolytic Anemia and Evans' syndrome: A Prospective Study.

Sirolimus for Refractory/relapsed Warm Autoimmune Hemolytic Anemia and Evans' syndrome: A Prospective Study.

Journal: Blood advances

Published: January 26, 2026

A Phosphorus-Modified Ultralow Content Ru Catalyst for Acetylene Hydrochlorination.

A Phosphorus-Modified Ultralow Content Ru Catalyst for Acetylene Hydrochlorination.

Journal: Langmuir : the ACS journal of surfaces and colloids

Published: January 08, 2026

Selinexor in combination with azacitidine or ruxolitinib in myelodysplastic/myeloproliferative neoplasm overlap syndromes: A multicenter prospective study.

Selinexor in combination with azacitidine or ruxolitinib in myelodysplastic/myeloproliferative neoplasm overlap syndromes: A multicenter prospective study.

Journal: Cancer

Published: December 26, 2025

Low-Dose Linperlisib Achieves Rapid Hematological Response in a Patient with Pure Red Cell Aplasia and Moderate-to-Severe Renal Insufficiency: A Case Report

Low-Dose Linperlisib Achieves Rapid Hematological Response in a Patient with Pure Red Cell Aplasia and Moderate-to-Severe Renal Insufficiency: A Case Report

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: December 03, 2025

Ultrasensitive colorimetric/fluorescence dual-mode sensing platform based on quasi-NENU-5 for specific detection of glyphosate.

Ultrasensitive colorimetric/fluorescence dual-mode sensing platform based on quasi-NENU-5 for specific detection of glyphosate.

Journal: Talanta

Published: November 23, 2025

Case Report: Early-onset VEXAS syndrome with recurrent pulmonary inflammation and myelodysplasia: a diagnostic and therapeutic challenge.

Case Report: Early-onset VEXAS syndrome with recurrent pulmonary inflammation and myelodysplasia: a diagnostic and therapeutic challenge.

Journal: Frontiers in immunology

Published: November 02, 2025

Prognostic Value of Next-Generation Flow Cytometry Versus Dual-Tracer PET/CT for Minimal Residual Disease Assessment in Multiple Myeloma.

Prognostic Value of Next-Generation Flow Cytometry Versus Dual-Tracer PET/CT for Minimal Residual Disease Assessment in Multiple Myeloma.

Journal: Cancer medicine

Published: October 17, 2025

Efficacy and safety of cyclosporine plus luspatercept versus cyclosporine in newly diagnosed non-transfusion-dependent non-severe aplastic anemia: A prospective randomized trial.

Efficacy and safety of cyclosporine plus luspatercept versus cyclosporine in newly diagnosed non-transfusion-dependent non-severe aplastic anemia: A prospective randomized trial.

Journal: BMC medicine

Published: October 17, 2025

Showing 1-12 of 139

Last Updated: 09/26/2026